nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—CCR1—Chemokine receptors bind chemokines—CXCR5—primary biliary cirrhosis	0.0263	0.0829	CbGpPWpGaD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CXCL9—primary biliary cirrhosis	0.0239	0.0753	CbGpPWpGaD
Raltegravir—CCR1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.0211	0.0664	CbGpPWpGaD
Raltegravir—UGT1A1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.0205	0.0646	CbGpPWpGaD
Raltegravir—Skin papilloma—Ursodeoxycholic acid—primary biliary cirrhosis	0.0147	0.0216	CcSEcCtD
Raltegravir—Skin papilloma—Chenodeoxycholic acid—primary biliary cirrhosis	0.0147	0.0216	CcSEcCtD
Raltegravir—UGT1A1—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.0131	0.0413	CbGpPWpGaD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CXCL10—primary biliary cirrhosis	0.0125	0.0392	CbGpPWpGaD
Raltegravir—Drug hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.0119	0.0174	CcSEcCtD
Raltegravir—Drug hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.0119	0.0174	CcSEcCtD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.0116	0.0366	CbGpPWpGaD
Raltegravir—UGT1A1—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.0111	0.0351	CbGpPWpGaD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CCL5—primary biliary cirrhosis	0.0107	0.0338	CbGpPWpGaD
Raltegravir—Creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.0102	0.0149	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00991	0.0312	CbGpPWpGaD
Raltegravir—Blood glucose increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00937	0.0137	CcSEcCtD
Raltegravir—Blood glucose increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00937	0.0137	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.009	0.0283	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.00836	0.0263	CbGpPWpGaD
Raltegravir—Polyp—Ursodeoxycholic acid—primary biliary cirrhosis	0.00788	0.0116	CcSEcCtD
Raltegravir—Polyp—Chenodeoxycholic acid—primary biliary cirrhosis	0.00788	0.0116	CcSEcCtD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00776	0.0244	CbGpPWpGaD
Raltegravir—Blood creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.00776	0.0114	CcSEcCtD
Raltegravir—Myopathy—Colchicine—primary biliary cirrhosis	0.00761	0.0112	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.00759	0.0239	CbGpPWpGaD
Raltegravir—Cyst—Ursodeoxycholic acid—primary biliary cirrhosis	0.00717	0.0105	CcSEcCtD
Raltegravir—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.00717	0.0105	CcSEcCtD
Raltegravir—Peptic ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.00717	0.0105	CcSEcCtD
Raltegravir—Peptic ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.00717	0.0105	CcSEcCtD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00676	0.0213	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00665	0.0209	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00604	0.019	CbGpPWpGaD
Raltegravir—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00603	0.00884	CcSEcCtD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.00568	0.0179	CbGpPWpGaD
Raltegravir—Hepatocellular injury—Colchicine—primary biliary cirrhosis	0.00534	0.00782	CcSEcCtD
Raltegravir—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.0052	0.00763	CcSEcCtD
Raltegravir—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.0052	0.00763	CcSEcCtD
Raltegravir—Nocturia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00517	0.00758	CcSEcCtD
Raltegravir—Nocturia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00517	0.00758	CcSEcCtD
Raltegravir—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00507	0.00743	CcSEcCtD
Raltegravir—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00507	0.00743	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.00506	0.0159	CbGpPWpGaD
Raltegravir—Neck pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00485	0.00711	CcSEcCtD
Raltegravir—Neck pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00485	0.00711	CcSEcCtD
Raltegravir—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00485	0.00711	CcSEcCtD
Raltegravir—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00485	0.00711	CcSEcCtD
Raltegravir—Rash maculo-papular—Colchicine—primary biliary cirrhosis	0.00485	0.00711	CcSEcCtD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.00483	0.0152	CbGpPWpGaD
Raltegravir—Eructation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00471	0.0069	CcSEcCtD
Raltegravir—Eructation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00471	0.0069	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.00469	0.0148	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.0046	0.0145	CbGpPWpGaD
Raltegravir—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00434	0.00635	CcSEcCtD
Raltegravir—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00434	0.00635	CcSEcCtD
Raltegravir—Lymphadenopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00408	0.00598	CcSEcCtD
Raltegravir—Lymphadenopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00408	0.00598	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.00403	0.0127	CbGpPWpGaD
Raltegravir—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00402	0.00589	CcSEcCtD
Raltegravir—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00402	0.00589	CcSEcCtD
Raltegravir—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.004	0.00586	CcSEcCtD
Raltegravir—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.004	0.00586	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.00395	0.0125	CbGpPWpGaD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00376	0.0118	CbGpPWpGaD
Raltegravir—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00371	0.00543	CcSEcCtD
Raltegravir—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00371	0.00543	CcSEcCtD
Raltegravir—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00366	0.00536	CcSEcCtD
Raltegravir—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00366	0.00536	CcSEcCtD
Raltegravir—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00363	0.00532	CcSEcCtD
Raltegravir—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00358	0.00525	CcSEcCtD
Raltegravir—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00358	0.00525	CcSEcCtD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.00356	0.0112	CbGpPWpGaD
Raltegravir—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00349	0.00511	CcSEcCtD
Raltegravir—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.00343	0.00502	CcSEcCtD
Raltegravir—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.00343	0.00502	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00342	0.00501	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.0034	0.0107	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.00338	0.0106	CbGpPWpGaD
Raltegravir—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00336	0.00492	CcSEcCtD
Raltegravir—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00336	0.00492	CcSEcCtD
Raltegravir—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00478	CcSEcCtD
Raltegravir—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00478	CcSEcCtD
Raltegravir—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00321	0.0047	CcSEcCtD
Raltegravir—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00466	CcSEcCtD
Raltegravir—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00466	CcSEcCtD
Raltegravir—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00315	0.00461	CcSEcCtD
Raltegravir—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00315	0.00461	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.00314	0.0099	CbGpPWpGaD
Raltegravir—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00459	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00459	CcSEcCtD
Raltegravir—Neutropenia—Colchicine—primary biliary cirrhosis	0.00313	0.00459	CcSEcCtD
Raltegravir—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00308	0.00451	CcSEcCtD
Raltegravir—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00308	0.00451	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00307	0.0045	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00307	0.0045	CcSEcCtD
Raltegravir—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00301	0.00441	CcSEcCtD
Raltegravir—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00301	0.00441	CcSEcCtD
Raltegravir—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00293	0.00429	CcSEcCtD
Raltegravir—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00289	0.00424	CcSEcCtD
Raltegravir—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00289	0.00424	CcSEcCtD
Raltegravir—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00423	CcSEcCtD
Raltegravir—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00423	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00286	0.00901	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.00285	0.00897	CbGpPWpGaD
Raltegravir—Haematuria—Colchicine—primary biliary cirrhosis	0.00285	0.00417	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0028	0.0041	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0028	0.0041	CcSEcCtD
Raltegravir—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00401	CcSEcCtD
Raltegravir—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00401	CcSEcCtD
Raltegravir—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00399	CcSEcCtD
Raltegravir—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00399	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.00271	0.00852	CbGpPWpGaD
Raltegravir—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00393	CcSEcCtD
Raltegravir—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00393	CcSEcCtD
Raltegravir—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00393	CcSEcCtD
Raltegravir—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00393	CcSEcCtD
Raltegravir—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00392	CcSEcCtD
Raltegravir—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00392	CcSEcCtD
Raltegravir—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00267	0.00391	CcSEcCtD
Raltegravir—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00388	CcSEcCtD
Raltegravir—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00388	CcSEcCtD
Raltegravir—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00386	CcSEcCtD
Raltegravir—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00386	CcSEcCtD
Raltegravir—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00385	CcSEcCtD
Raltegravir—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00385	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.0026	0.00818	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.0026	0.00818	CbGpPWpGaD
Raltegravir—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00375	CcSEcCtD
Raltegravir—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00375	CcSEcCtD
Raltegravir—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00372	CcSEcCtD
Raltegravir—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00372	CcSEcCtD
Raltegravir—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00371	CcSEcCtD
Raltegravir—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00371	CcSEcCtD
Raltegravir—Eye disorder—Colchicine—primary biliary cirrhosis	0.00251	0.00367	CcSEcCtD
Raltegravir—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00242	0.00354	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.00239	0.00754	CbGpPWpGaD
Raltegravir—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00349	CcSEcCtD
Raltegravir—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00349	CcSEcCtD
Raltegravir—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00348	CcSEcCtD
Raltegravir—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00348	CcSEcCtD
Raltegravir—Alopecia—Colchicine—primary biliary cirrhosis	0.00237	0.00347	CcSEcCtD
Raltegravir—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00347	CcSEcCtD
Raltegravir—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00347	CcSEcCtD
Raltegravir—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00346	CcSEcCtD
Raltegravir—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00346	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00236	0.00743	CbGpPWpGaD
Raltegravir—Malnutrition—Colchicine—primary biliary cirrhosis	0.00233	0.00342	CcSEcCtD
Raltegravir—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00232	0.0034	CcSEcCtD
Raltegravir—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00232	0.0034	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.00226	0.00713	CbGpPWpGaD
Raltegravir—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0033	CcSEcCtD
Raltegravir—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0033	CcSEcCtD
Raltegravir—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00329	CcSEcCtD
Raltegravir—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00329	CcSEcCtD
Raltegravir—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00328	CcSEcCtD
Raltegravir—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00328	CcSEcCtD
Raltegravir—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0032	CcSEcCtD
Raltegravir—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0032	CcSEcCtD
Raltegravir—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00319	CcSEcCtD
Raltegravir—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00319	CcSEcCtD
Raltegravir—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00318	CcSEcCtD
Raltegravir—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00318	CcSEcCtD
Raltegravir—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00216	0.00317	CcSEcCtD
Raltegravir—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00216	0.00317	CcSEcCtD
Raltegravir—Anaemia—Colchicine—primary biliary cirrhosis	0.00216	0.00316	CcSEcCtD
Raltegravir—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00312	CcSEcCtD
Raltegravir—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00312	CcSEcCtD
Raltegravir—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00307	CcSEcCtD
Raltegravir—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00307	CcSEcCtD
Raltegravir—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00303	CcSEcCtD
Raltegravir—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00303	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.00206	0.00649	CbGpPWpGaD
Raltegravir—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00298	CcSEcCtD
Raltegravir—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00298	CcSEcCtD
Raltegravir—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00297	CcSEcCtD
Raltegravir—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00297	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.00201	0.00632	CbGpPWpGaD
Raltegravir—Myalgia—Colchicine—primary biliary cirrhosis	0.00199	0.00291	CcSEcCtD
Raltegravir—Arthralgia—Colchicine—primary biliary cirrhosis	0.00199	0.00291	CcSEcCtD
Raltegravir—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00285	CcSEcCtD
Raltegravir—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00285	CcSEcCtD
Raltegravir—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00284	CcSEcCtD
Raltegravir—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00284	CcSEcCtD
Raltegravir—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00277	CcSEcCtD
Raltegravir—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00277	CcSEcCtD
Raltegravir—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00276	CcSEcCtD
Raltegravir—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00276	CcSEcCtD
Raltegravir—UGT1A1—Phase II conjugation—GGT1—primary biliary cirrhosis	0.00188	0.00592	CbGpPWpGaD
Raltegravir—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00187	0.00274	CcSEcCtD
Raltegravir—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00186	0.00273	CcSEcCtD
Raltegravir—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00271	CcSEcCtD
Raltegravir—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00271	CcSEcCtD
Raltegravir—Skin disorder—Colchicine—primary biliary cirrhosis	0.00185	0.00271	CcSEcCtD
Raltegravir—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00268	CcSEcCtD
Raltegravir—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00268	CcSEcCtD
Raltegravir—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00265	CcSEcCtD
Raltegravir—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00265	CcSEcCtD
Raltegravir—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00262	CcSEcCtD
Raltegravir—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00262	CcSEcCtD
Raltegravir—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00262	CcSEcCtD
Raltegravir—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00262	CcSEcCtD
Raltegravir—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00262	CcSEcCtD
Raltegravir—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00262	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.0026	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.0026	CcSEcCtD
Raltegravir—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00258	CcSEcCtD
Raltegravir—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00258	CcSEcCtD
Raltegravir—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00256	CcSEcCtD
Raltegravir—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00256	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00174	0.00254	CcSEcCtD
Raltegravir—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00173	0.00253	CcSEcCtD
Raltegravir—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00173	0.00253	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.00172	0.00543	CbGpPWpGaD
Raltegravir—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00249	CcSEcCtD
Raltegravir—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00249	CcSEcCtD
Raltegravir—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00246	CcSEcCtD
Raltegravir—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00246	CcSEcCtD
Raltegravir—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00245	CcSEcCtD
Raltegravir—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00245	CcSEcCtD
Raltegravir—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00244	CcSEcCtD
Raltegravir—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00244	CcSEcCtD
Raltegravir—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00166	0.00243	CcSEcCtD
Raltegravir—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00242	CcSEcCtD
Raltegravir—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00242	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00164	0.00241	CcSEcCtD
Raltegravir—Fatigue—Colchicine—primary biliary cirrhosis	0.00164	0.00241	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.00159	0.00502	CbGpPWpGaD
Raltegravir—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00228	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00228	CcSEcCtD
Raltegravir—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00156	0.00228	CcSEcCtD
Raltegravir—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00227	CcSEcCtD
Raltegravir—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00227	CcSEcCtD
Raltegravir—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00225	CcSEcCtD
Raltegravir—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00225	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.00153	0.00483	CbGpPWpGaD
Raltegravir—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00223	CcSEcCtD
Raltegravir—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00223	CcSEcCtD
Raltegravir—Urticaria—Colchicine—primary biliary cirrhosis	0.00151	0.00222	CcSEcCtD
Raltegravir—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00221	CcSEcCtD
Raltegravir—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00221	CcSEcCtD
Raltegravir—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00151	0.00221	CcSEcCtD
Raltegravir—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00218	CcSEcCtD
Raltegravir—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00218	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00216	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00216	CcSEcCtD
Raltegravir—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00216	CcSEcCtD
Raltegravir—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00216	CcSEcCtD
Raltegravir—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00214	CcSEcCtD
Raltegravir—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00214	CcSEcCtD
Raltegravir—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00214	CcSEcCtD
Raltegravir—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00214	CcSEcCtD
Raltegravir—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.00207	CcSEcCtD
Raltegravir—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.00207	CcSEcCtD
Raltegravir—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.0014	0.00206	CcSEcCtD
Raltegravir—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00205	CcSEcCtD
Raltegravir—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00205	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.00139	0.00439	CbGpPWpGaD
Raltegravir—Asthenia—Colchicine—primary biliary cirrhosis	0.00137	0.002	CcSEcCtD
Raltegravir—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00199	CcSEcCtD
Raltegravir—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00199	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00135	0.00426	CbGpPWpGaD
Raltegravir—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00198	CcSEcCtD
Raltegravir—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00198	CcSEcCtD
Raltegravir—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00198	CcSEcCtD
Raltegravir—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00198	CcSEcCtD
Raltegravir—Diarrhoea—Colchicine—primary biliary cirrhosis	0.0013	0.00191	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.00129	0.00406	CbGpPWpGaD
Raltegravir—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00185	CcSEcCtD
Raltegravir—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00185	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—GGT1—primary biliary cirrhosis	0.00125	0.00395	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.00123	0.00387	CbGpPWpGaD
Raltegravir—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0018	CcSEcCtD
Raltegravir—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0018	CcSEcCtD
Raltegravir—Vomiting—Colchicine—primary biliary cirrhosis	0.00121	0.00177	CcSEcCtD
Raltegravir—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00177	CcSEcCtD
Raltegravir—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00177	CcSEcCtD
Raltegravir—Rash—Colchicine—primary biliary cirrhosis	0.0012	0.00176	CcSEcCtD
Raltegravir—Dermatitis—Colchicine—primary biliary cirrhosis	0.0012	0.00176	CcSEcCtD
Raltegravir—Headache—Colchicine—primary biliary cirrhosis	0.00119	0.00175	CcSEcCtD
Raltegravir—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00172	CcSEcCtD
Raltegravir—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00172	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.00116	0.00367	CbGpPWpGaD
Raltegravir—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00166	CcSEcCtD
Raltegravir—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00166	CcSEcCtD
Raltegravir—Nausea—Colchicine—primary biliary cirrhosis	0.00113	0.00166	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.00112	0.00353	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GGT1—primary biliary cirrhosis	0.0011	0.00346	CbGpPWpGaD
Raltegravir—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00159	CcSEcCtD
Raltegravir—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00159	CcSEcCtD
Raltegravir—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00158	CcSEcCtD
Raltegravir—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00158	CcSEcCtD
Raltegravir—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00158	CcSEcCtD
Raltegravir—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00158	CcSEcCtD
Raltegravir—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00157	CcSEcCtD
Raltegravir—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00157	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.00106	0.00333	CbGpPWpGaD
Raltegravir—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00149	CcSEcCtD
Raltegravir—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00149	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000974	0.00307	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000885	0.00279	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LBR—primary biliary cirrhosis	0.000757	0.00238	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000726	0.00229	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000662	0.00208	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000662	0.00208	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000625	0.00197	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000605	0.00191	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—OGDH—primary biliary cirrhosis	0.000547	0.00172	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000525	0.00165	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGT—primary biliary cirrhosis	0.000523	0.00165	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PDHX—primary biliary cirrhosis	0.000488	0.00154	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CD80—primary biliary cirrhosis	0.000463	0.00146	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—DLAT—primary biliary cirrhosis	0.000458	0.00144	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCB4—primary biliary cirrhosis	0.000458	0.00144	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000391	0.00123	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000308	0.000969	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	0.000305	0.000959	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NUP210—primary biliary cirrhosis	0.000275	0.000868	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCG2—primary biliary cirrhosis	0.000256	0.000807	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CTGF—primary biliary cirrhosis	0.00022	0.000692	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT2—primary biliary cirrhosis	0.000218	0.000686	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT1—primary biliary cirrhosis	0.000188	0.000592	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT1—primary biliary cirrhosis	0.000188	0.000592	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000167	0.000527	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AGT—primary biliary cirrhosis	0.00013	0.00041	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—primary biliary cirrhosis	0.0001	0.000315	CbGpPWpGaD
